Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement-Reference-Cited by-同舟云学术

Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement

Published:2024-02 Issue:3 Volume:17 Page:405-418
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Alaour Bashir,Ferrari Enrico,Heg Dik,Tueller David,Pilgrim Thomas,Muller Olivier,Noble Stephane^ORCID,Jeger Raban,Reuthebuch Oliver,Toggweiler Stefan,Templin Christian,Wenaweser Peter,Nietlispach Fabian,Taramasso Maurizio,Huber Christoph,Roffi Marco,Windecker Stephan,Stortecky Stefan^ORCID

Publisher

Elsevier BV

Reference33 articles.

1. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT prospective multicenter registry;Tarantini;J Am Coll Cardiol Intv,2016

2. for STOP-AS and France-TAVI. TAVR patients requiring anticoagulation: direct oral anticoagulant or vitamin K antagonist?;Didier;J Am Coll Cardiol Intv,2021

3. Use of direct oral anticoagulant and outcomes in patients with atrial fibrillation after transcatheter aortic valve replacement: insights from the STS/ACC TVT Registry;Tanawuttiwat;J Am Heart Assoc,2022

4. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valve (PARTNER) trial;Biviano;Circ Cardiovasc Interv,2016

5. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation;Stortecky;Circ Cardiovasc Interv,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic therapy for transcatheter structural heart intervention;EuroIntervention;2024-08

2. What Oral Anticoagulant Is Best After TAVR;JACC: Cardiovascular Interventions;2024-02